相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Excessive Activation of Notch Signaling in Macrophages Promote Kidney Inflammation, Fibrosis, and Necroptosis
Tiankui Ma et al.
FRONTIERS IN IMMUNOLOGY (2022)
SMYD2-mediated TRAF2 methylation promotes the NF-κB signaling pathways in inflammatory diseases
Weijun Wu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys
Xiaojing Yang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)
Mechanism for DPY30 and ASH2L intrinsically disordered regions to modulate the MLL/SET1 activity on chromatin
Young-Tae Lee et al.
NATURE COMMUNICATIONS (2021)
Epigenetics and Inflammation in Diabetic Nephropathy
Bao-Yi Shao et al.
FRONTIERS IN PHYSIOLOGY (2021)
HIPK2 phosphorylates HDAC3 for NF-κB acetylation to ameliorate colitis-associated colorectal carcinoma and sepsis
Fang Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1
Shuyu Zhai et al.
ONCOGENE (2021)
High Glucose Induces Mesangial Cell Apoptosis through miR-15b-5p and Promotes Diabetic Nephropathy by Extracellular Vesicle Delivery
Yi-Chun Tsai et al.
MOLECULAR THERAPY (2020)
Innate immunity in diabetic kidney disease
Sydney C. W. Tang et al.
NATURE REVIEWS NEPHROLOGY (2020)
ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription
Kai Zeng et al.
CANCER SCIENCE (2020)
New therapeutic targets in chronic kidney disease progression and renal fibrosis
Sandra Rayego-Mateos et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Macrophage Phenotype and Fibrosis in Diabetic Nephropathy
Priscila Calle et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Butyrate alleviates diabetic kidney disease by mediating the miR-7a-5p/P311/TGF-beta 1 pathway
Yi Du et al.
FASEB JOURNAL (2020)
Tubular HIPK2 is a key contributor to renal fibrosis
Wenzhen Xiao et al.
JCI INSIGHT (2020)
Specific inhibition of DPY30 activity by ASH2L-derived peptides suppresses blood cancer cell growth
Kushani K. Shah et al.
EXPERIMENTAL CELL RESEARCH (2019)
Structural basis of nucleosome recognition and modification by MLL methyltransferases
Han Xue et al.
NATURE (2019)
Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma
Yan Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice
Chao Zheng et al.
CELL DEATH & DISEASE (2019)
EGFR drives the progression of AKI to CKD through HIPK2 overexpression
Luyang Xu et al.
THERANOSTICS (2019)
Inflammation and fibrosis
Matthias Mack
MATRIX BIOLOGY (2018)
Mitochondrial dysfunction in diabetic kidney disease
Josephine M. Forbes et al.
NATURE REVIEWS NEPHROLOGY (2018)
A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-β1/Smad3 Pathway
Ruijie Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
The role of the complement system in diabetic nephropathy
Allan Flyvbjerg
NATURE REVIEWS NEPHROLOGY (2017)
Diabetic nephropathy - is this an immune disorder?
Greg H. Tesch
CLINICAL SCIENCE (2017)
Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy
Hyung Jung Oh et al.
SCIENTIFIC REPORTS (2016)
Homeodomain-Interacting Protein Kinase-2: A Critical Regulator of the DNA Damage Response and the Epigenome
Yuki Kuwano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2
Howard Donninger et al.
JOURNAL OF CELL BIOLOGY (2015)
HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease
Melinda M. Nugent et al.
FRONTIERS IN PHYSIOLOGY (2015)
Diabetic kidney disease
Merlin C. Thomas et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Absent, Small or Homeotic 2-like Protein (ASH2L) Enhances the Transcription of the Estrogen Receptor α Gene through GATA-binding Protein 3 (GATA3)
Jin Qi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Changes in Diabetes-Related Complications in the United States, 1990-2010
Edward W. Gregg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Role of HIPK2 in kidney fibrosis
Ying Fan et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2014)
Glucose-independent persistence of PAI-1 gene expression and H3K4 tri-methylation in type 1 diabetic mouse endothelium: Implication in metabolic memory
Fumihiko Takizawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Inflammation and the pathogenesis of diabetic nephropathy
Jun Wada et al.
CLINICAL SCIENCE (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Updates on HIPK2: a resourceful oncosuppressor for clearing cancer
Gabriella D'Orazi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
A systems approach identifies HIPK2 as a key regulator of kidney fibrosis
Yuanmeng Jin et al.
NATURE MEDICINE (2012)
Inflammation in Diabetic Nephropathy
Andy K. H. Lim et al.
MEDIATORS OF INFLAMMATION (2012)
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Yashpal S. Kanwar et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Structural analysis of the core COMPASS family of histone H3K4 methylases from yeast to human
Yoh-hei Takahashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
Maoyin Pang et al.
KIDNEY INTERNATIONAL (2010)
Mechanisms of glomerulosclerosis in diabetic nephropathy
Ying Qian et al.
DIABETES (2008)
Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes
Melissa M. Steward et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)
Merlin C. Thomas et al.
MEDICAL JOURNAL OF AUSTRALIA (2006)
Diabetic nephropathy: Diagnosis, prevention, and treatment
JL Gross et al.
DIABETES CARE (2005)
New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology
G Wolf
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
分享论文
